Cited by 260

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

SirT1 Regulates Adipose Tissue Inflammation

Gillum, Matthew P., Kotas, Maya E., Erion, Derek M., Kursawe, Romy, Chatterjee, Paula, Nead, Kevin T., Muise, Eric S., Hsiao, Jennifer J., Frederick, David W., Yonemitsu, Shin, Banks, Alexander S., Qiang, Li, Bhanot, Sanjay, Olefsky, Jerrold M., Sears, Dorothy D., Caprio, Sonia, Shulman, Gerald I.·2011·Diabetes

Abstract

OBJECTIVE: Macrophage recruitment to adipose tissue is a reproducible feature of obesity. However, the events that result in chemokine production and macrophage recruitment to adipose tissue during states of energetic excess are not clear. Sirtuin 1 (SirT1) is an essential nutrient-sensing histone deacetylase, which is increased by caloric restriction and reduced by overfeeding. We discovered that SirT1 depletion causes anorexia by stimulating production of inflammatory factors in white adipose tissue and thus posit that decreases in SirT1 link overnutrition and adipose tissue inflammation. RESEARCH DESIGN AND METHODS: We used antisense oligonucleotides to reduce SirT1 to levels similar to those seen during overnutrition and studied SirT1-overexpressing transgenic mice and fat-specific SirT1 knockout animals. Finally, we analyzed subcutaneous adipose tissue biopsies from two independent cohorts of human subjects. RESULTS: We found that inducible or genetic reduction of SirT1 in vivo causes macrophage recruitment to adipose tissue, whereas overexpression of SirT1 prevents adipose tissue macrophage accumulation caused by chronic high-fat feeding. We also found that SirT1 expression in human subcutaneous fat is inversely related to adipose tissue macrophage infiltration. CONCLUSIONS: Reduction of adipose tissue SirT1 expression, which leads to histone hyperacetylation and ectopic inflammatory gene expression, is identified as a key regulatory component of macrophage influx into adipose tissue during overnutrition in rodents and humans. Our results suggest that SirT1 regulates adipose tissue inflammation by controlling the gain of proinflammatory transcription in response to inducers such as fatty acids, hypoxia, and endoplasmic reticulum stress.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db11-0616

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Reduction of SIRT1 levels correlates with the development and progression of many inflammatory diseases.

    “reduction of SIRT1 levels correlates with the development and progression of many inflammatory diseases”

    From The Hallmarks of Aging (2013) · cites this paper as Gillum et al., 2011

    The Results (Fig. 6; page unavailable) report an inverse correlation between SirT1 expression and macrophage markers in human adipose tissue. The Conclusions (page unavailable) link reduced SirT1 to adipose tissue inflammation during overnutrition. The paper does not establish a correlation with the development or progression of many inflammatory diseases; that extends beyond the condition studied. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Pharmacologic activation of SIRT1 may prevent inflammatory responses in mice.

    “pharmacologic activation of SIRT1 may prevent inflammatory responses in mice”

    From The Hallmarks of Aging (2013) · cites this paper as Gillum et al., 2011

    The Results section reports that genetic SirT1 overexpression reduced high-fat-diet-induced adipose tissue inflammation in mice. It does not establish that pharmacologic activation has this effect; the paper also cautions that polyphenols used to modify SirT1 function are not direct activators. Its findings are specific to the high-fat-diet setting, while SirT1-overexpressing mice on regular chow showed elevated inflammatory markers. Page numbers are unavailable in our copy. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 31

  1. Cinti, 2005, Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans, J Lipid Res, 46, 2347, 10.1194/jlr.M500294-JLR200 · DOI · Paper page
  2. Sabio, 2008, A stress signaling pathway in adipose tissue regulates hepatic insulin resistance, Science, 322, 1539, 10.1126/science.1160794 · DOI · Paper page
  3. Ozcan, 2004, Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes, Science, 306, 457, 10.1126/science.1103160 · DOI · Paper page
  4. Rodgers, 2007, Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1, Proc Natl Acad Sci USA, 104, 12861, 10.1073/pnas.0702509104 · DOI · Paper page
  5. Chen, 2007, SIR2: a potential target for calorie restriction mimetics, Trends Mol Med, 13, 64, 10.1016/j.molmed.2006.12.004 · DOI
  6. Purushotham, 2009, Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation, Cell Metab, 9, 327, 10.1016/j.cmet.2009.02.006 · DOI · Paper page
  7. Erion, 2009, SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats, Proc Natl Acad Sci USA, 106, 11288, 10.1073/pnas.0812931106 · DOI
  8. Banks, 2008, SirT1 gain of function increases energy efficiency and prevents diabetes in mice, Cell Metab, 8, 333, 10.1016/j.cmet.2008.08.014 · DOI
  9. Qiao, 2006, SIRT1 regulates adiponectin gene expression through Foxo1-C/enhancer-binding protein alpha transcriptional complex, J Biol Chem, 281, 39915, 10.1074/jbc.M607215200 · DOI
  10. Ghosh, 2007, Sirt1 interacts with transducin-like enhancer of split-1 to inhibit nuclear factor kappaB-mediated transcription, Biochem J, 408, 105, 10.1042/BJ20070817 · DOI
  11. Yoshizaki, 2009, SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes, Mol Cell Biol, 29, 1363, 10.1128/MCB.00705-08 · DOI
  12. Pfluger, 2008, Sirt1 protects against high-fat diet-induced metabolic damage, Proc Natl Acad Sci USA, 105, 9793, 10.1073/pnas.0802917105 · DOI · Paper page
  13. Kaeberlein, 2005, Substrate-specific activation of sirtuins by resveratrol, J Biol Chem, 280, 17038, 10.1074/jbc.M500655200 · DOI · Paper page
  14. Vaquero, 2004, Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin, Mol Cell, 16, 93, 10.1016/j.molcel.2004.08.031 · DOI · Paper page
  15. Liu, 2011, NAD+-dependent SIRT1 deacetylase participates in epigenetic reprogramming during endotoxin tolerance, J Biol Chem, 286, 9856, 10.1074/jbc.M110.196790 · DOI
  16. Luo, 2010, Macrophage adiponectin expression improves insulin sensitivity and protects against inflammation and atherosclerosis, Diabetes, 59, 791, 10.2337/db09-1338 · DOI
  17. Cali’, 2008, Metabolic abnormalities underlying the different prediabetic phenotypes in obese adolescents, J Clin Endocrinol Metab, 93, 1767, 10.1210/jc.2007-1722 · DOI
  18. Burgert, 2006, Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat, J Clin Endocrinol Metab, 91, 4287, 10.1210/jc.2006-1010 · DOI
  19. Cali, 2009, Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link?, Hepatology, 49, 1896, 10.1002/hep.22858 · DOI
  20. Sears, 2009, Mechanisms of human insulin resistance and thiazolidinedione-mediated insulin sensitization, Proc Natl Acad Sci USA, 106, 18745, 10.1073/pnas.0903032106 · DOI
  21. Nagai, 2009, The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance, Cell Metab, 9, 252, 10.1016/j.cmet.2009.01.011 · DOI · Paper page
  22. Matarese, 2004, The intricate interface between immune system and metabolism, Trends Immunol, 25, 193, 10.1016/j.it.2004.02.009 · DOI
  23. Nie, 2009, STAT3 inhibition of gluconeogenesis is downregulated by SirT1, Nat Cell Biol, 11, 492, 10.1038/ncb1857 · DOI
  24. Mamane, 2009, The C3a anaphylatoxin receptor is a key mediator of insulin resistance and functions by modulating adipose tissue macrophage infiltration and activation, Diabetes, 58, 2006, 10.2337/db09-0323 · DOI
  25. Kawahara, 2009, SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span, Cell, 136, 62, 10.1016/j.cell.2008.10.052 · DOI · Paper page
  26. Makris, 2000, Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti, Mol Cell, 5, 969, 10.1016/S1097-2765(00)80262-2 · DOI
  27. Pasparakis, 2009, Regulation of tissue homeostasis by NF-kappaB signalling: implications for inflammatory diseases, Nat Rev Immunol, 9, 778, 10.1038/nri2655 · DOI
  28. Savage, 2007, Disordered lipid metabolism and the pathogenesis of insulin resistance, Physiol Rev, 87, 507, 10.1152/physrev.00024.2006 · DOI · Paper page
  29. Cani, 2007, Metabolic endotoxemia initiates obesity and insulin resistance, Diabetes, 56, 1761, 10.2337/db06-1491 · DOI · Paper page
  30. Vaziri, 2001, hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase, Cell, 107, 149, 10.1016/S0092-8674(01)00527-X · DOI
  31. Picard, 2004, Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma, Nature, 429, 771, 10.1038/nature02583 · DOI

Cited by

Sorted by citations

Metadata

Authors
Gillum, M. P., Kotas, M. E., Erion, D. M., Kursawe, R., Chatterjee, P., Nead, K. T., Muise, E. S., Hsiao, J. J., Frederick, D. W., Yonemitsu, S., Banks, A. S., Qiang, L., Bhanot, S., Olefsky, J. M., Sears, D. D., Caprio, S., & Shulman, G. I.
Affiliations
  • Howard Hughes Medical Institute, Chevy Chase, Maryland
  • Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut
  • Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut
  • Merck, Rahway, New Jersey
  • Department of Cell Biology, Harvard School of Medicine, Boston, Massachusetts
  • Columbia University, New York, New York
  • Isis Pharmaceuticals, Carlsbad, California
  • University of California San Diego, San Diego, California
Venue
Diabetes
Published
2011-11-13
Volume
60
Issue
12
Pages
3235-3245
ISSN
  • 0012-1797
  • 1939-327X
Cited by
260
References
17
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review